414 related articles for article (PubMed ID: 24462368)
1. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
4. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
[TBL] [Abstract][Full Text] [Related]
5. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.
Furlan A; Marin D; Cabassa P; Taibbi A; Brunelli E; Agnello F; Lagalla R; Brancatelli G
Eur J Radiol; 2012 Sep; 81(9):2099-105. PubMed ID: 21906896
[TBL] [Abstract][Full Text] [Related]
6. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
[TBL] [Abstract][Full Text] [Related]
7. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
8. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
[TBL] [Abstract][Full Text] [Related]
9. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K
Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
12. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
13. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
[TBL] [Abstract][Full Text] [Related]
14. Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis.
Sorrentino P; Tarantino L; D'Angelo S; Terracciano L; Ferbo U; Bracigliano A; Panico L; De Chiara G; Lepore M; De Stefano N; Fiorentino F; Vecchione R
J Gastroenterol Hepatol; 2011 Apr; 26(4):669-77. PubMed ID: 21054520
[TBL] [Abstract][Full Text] [Related]
15. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
17. Imaging of HCC.
Ayuso C; Rimola J; García-Criado A
Abdom Imaging; 2012 Apr; 37(2):215-30. PubMed ID: 21909721
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the American Association for the Study of Liver Disease and Barcelona criteria for the diagnosis of hepatocellular carcinoma.
Pahwa A; Beckett K; Channual S; Tan N; Lu DS; Raman SS
Abdom Imaging; 2014 Aug; 39(4):753-60. PubMed ID: 24699935
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].
Ouedraogo W; Tran-Van Nhieu J; Baranes L; Lin SJ; Decaens T; Laurent A; Djabbari M; Pigneur F; Duvoux C; Kobeiter H; Deux JF; Rahmouni A; Luciani A
J Radiol; 2011; 92(7-8):688-700. PubMed ID: 21819911
[TBL] [Abstract][Full Text] [Related]
20. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
